PVLA
PALVELLA THERAPEUTICS, INC.Company Information
- Company Name
- PALVELLA THERAPEUTICS, INC.
- CIK
- CIK0001583648
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- PVLA: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- PVLA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-30
- Last sale
- 2026-09-16
- Shares purchased (TTM)
- 6,845
- Shares sold (TTM)
- 49,412
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 13,451,194
- Shares outstanding
- 14,356,219
- Ownership
- 93.70%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- -1.33%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 188 | 206 | 58 | 64 | 70 | 76 | 84 | 19 | 20 | 19 | 7 | 33 | ||||||
| Accounts Receivable Net Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 1 | ||||||
| Grants Receivable Current | - | - | - | - | - | - | - | 0 | 3 | 3 | 3 | - | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | 1 | 0 | 2 | 2 | - | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 2 | 2 | ||||||
| Short Term Investments | 63 | 55 | - | - | - | - | - | 0 | 0 | 0 | 9 | 12 | ||||||
| Prepaid Expense And Other Assets Current | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 0 | 1 | 3 | 0 | 9 | ||||||
| Assets Current | 253 | 263 | 59 | 67 | 74 | 79 | 88 | - | - | - | 8 | 59 | ||||||
| Operating Lease Right Of Use Asset | 0 | 1 | 1 | - | - | - | 0 | - | - | - | - | 0 | ||||||
| Assets | 254 | 264 | 60 | 67 | 74 | 79 | 88 | 21 | 25 | 29 | 8 | 59 | ||||||
Liabilities Current | ||||||||||||||||||
| Property Plant And Equipment Net | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Payable Current | 7 | 5 | 5 | 3 | 5 | 4 | 5 | 1 | 1 | 2 | 1 | 3 | ||||||
| Other Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Derivative Liabilities Current | 0 | 0 | 2 | 2 | 2 | 2 | 2 | - | - | - | 0 | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | 12 | ||||||
| Liabilities Current | 12 | 9 | 11 | 10 | 10 | 9 | 12 | 4 | 6 | 8 | 2 | 29 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | - | - | - | 0 | - | - | - | 0 | 0 | ||||||
| Derivative Liabilities Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | - | - | 1 | - | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | - | - | - | - | 0 | - | - | - | 71 | - | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities | 37 | 31 | 32 | 28 | 26 | 24 | 26 | - | - | - | 11 | 29 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 1 | ||||||
| Preferred Stock Value | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 390 | 383 | 163 | 161 | 159 | 157 | 156 | 343 | 343 | 342 | 2 | 341 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -173 | -151 | -135 | -123 | -111 | -102 | -94 | -326 | -323 | -320 | -76 | -310 | ||||||
| Stockholders Equity | 217 | 232 | 28 | 39 | 48 | 56 | 63 | -87 | -81 | -77 | -74 | 31 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | - | - | - | 0.00 | - | ||||||
| Temporary Equity Shares Authorized | - | - | - | - | - | - | 0 | - | - | - | 21 | - | ||||||
| Liabilities And Stockholders Equity | 254 | 264 | 60 | 67 | 74 | 79 | 88 | 21 | 25 | 29 | 8 | 59 | ||||||
| Temporary Equity Shares Issued | - | - | - | - | - | - | 0 | - | - | - | 15 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Temporary Equity Shares Outstanding | - | - | - | - | - | - | 0 | - | - | - | 15 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | - | 10 | 10 | 10 | 10 | 10 | 10 | - | - | - | 10 | - | ||||||
| Preferred Stock Shares Issued | - | - | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Temporary Equity Liquidation Preference | - | - | - | - | - | - | 0 | - | - | - | 65 | - | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | - | - | - | 9 | - | ||||||
| Common Stock Shares Issued | 14 | 14 | 12 | 11 | 11 | 11 | 5 | - | - | - | 2 | - | ||||||
| Preferred Stock Shares Outstanding | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Shares Outstanding | 14 | 14 | 12 | 11 | 11 | 11 | 11 | - | - | - | 2 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialPALVELLA THERAPEUTICS, INC. (PVLA) — SEC Financial Statements & Analysis
PALVELLA THERAPEUTICS, INC. (PVLA) is a pharmaceutical preparations company, incorporated in NV. PALVELLA THERAPEUTICS, INC. trades on Nasdaq as: PVLA. PALVELLA THERAPEUTICS, INC. (PVLA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, PALVELLA THERAPEUTICS, INC. carries a market cap of $2.19B, a P/E ratio of -35.56x, a P/B ratio of 10.12x, a P/S ratio of 4451.87x, an enterprise value of $2.01B, and an EV/EBITDA multiple of -34.74x. On profitability, it posts an operating margin of -234916.67%, a net margin of -290566.67%, a Return on Equity (ROE) of -46.63%, a Return on Assets (ROA) of -37.70%, and a Return on Invested Capital (ROIC) of -1801.31%. Per share, it reports EPS of $-4.30, diluted EPS of $-4.30, free cash flow per share of $-2.54, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 118.87% year-over-year, and EPS growth of 68.51% year-over-year. On the balance sheet, it maintains a current ratio of 21.18x, a quick ratio of 20.97x, working capital of $241.08M, a debt-to-equity ratio of 0.17x, a debt ratio of 0.14, an interest coverage ratio of -13.79x, free cash flow of $-36.51M (TTM), and net debt of $-187.80M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.19B
- P/E TTM
- -35.56x
- EPS TTM
- $-4.30
- P/B TTM
- 10.12x
- ROE TTM
- -46.63%
- ROA TTM
- -37.70%
- Debt To Equity
- 0.17x
- Free Cash Flow TTM
- $-36.51M
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PALVELLA THERAPEUTICS, INC. in?
PALVELLA THERAPEUTICS, INC. (PVLA) operates in the Pharmaceutical Preparations industry.
What exchange does PVLA trade on?
PALVELLA THERAPEUTICS, INC. (PVLA) trades on the Nasdaq.
Where is PALVELLA THERAPEUTICS, INC. incorporated?
PALVELLA THERAPEUTICS, INC. is incorporated in NV.
When was PALVELLA THERAPEUTICS, INC. (PVLA)'s most recent SEC filing?
PALVELLA THERAPEUTICS, INC. (PVLA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is PVLA's market cap?
PALVELLA THERAPEUTICS, INC. (PVLA) has a market capitalization of $2.19B as of 2026-06-30.
What is PVLA's EPS (earnings per share)?
PALVELLA THERAPEUTICS, INC. (PVLA)'s trailing twelve month EPS is $-4.30 as of 2026-06-30.
What is PVLA's ROE (return on equity)?
PALVELLA THERAPEUTICS, INC. (PVLA)'s trailing twelve month Return on Equity (ROE) is -46.63% as of 2026-06-30.
What is PVLA's ROA (return on assets)?
PALVELLA THERAPEUTICS, INC. (PVLA)'s trailing twelve month Return on Assets (ROA) is -37.70% as of 2026-06-30.
What is PVLA's ROIC (return on invested capital)?
PALVELLA THERAPEUTICS, INC. (PVLA)'s trailing twelve month Return on Invested Capital (ROIC) is -1801.31% as of 2026-06-30.
What is PVLA's EV/EBITDA?
PALVELLA THERAPEUTICS, INC. (PVLA)'s trailing twelve month EV/EBITDA is -34.74x as of 2026-06-30.